The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing…
New alliance takes aim at inconsistent biomarker interpretation across pathologists, a persistent challenge in drug developmentHUNTSVILLE, Ala. and HAMBURG, Germany,…
MELBOURNE, March 16, 2026 (GLOBE NEWSWIRE) -- Imprivata, a leading provider of access management solutions for healthcare and other mission-critical…
SINGAPORE, March 12, 2026 /PRNewswire/ -- Emerald Clinical Trials, a leading global clinical research organization (CRO), today announced it has…
March 11, 2026 19:21 ET | Source: Mesoblast Limited NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…
From 100 to 600 patients: to support patients suffering from acne, Avène, Pierre Fabre Laboratories' leading brand, is strengthening the…
March 10, 2026 08:05 ET | Source: NKGen Biotech, Inc. SANTA ANA, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- NKGen…
Study is Real-World Evaluation of the Clinical Utility of Sodium Thiosulfate Injection (PEDMARK®) in Reducing the Risk of Ototoxicity in Adolescent…
Integrated Workflow Including Clinical Seed Production and StemEdit Gene Editing ServicesBELTSVILLE, Md., March 3, 2026 /PRNewswire/ -- REPROCELL (TYO: 4978) today…
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical…